Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (79)
  • 2024 (109)
  • 2023 (101)
  • 2022 (60)
  • 2021 (32)
  • 2020 (8)
  • 2019 (2)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (230)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (242)
  • Fentanyl Awareness (152)

Drug Name

  • Fentanyl (106)
  • Opioids (47)
  • Oxycodone (37)
  • Methamphetamine (18)
  • Synthetic Opioids (15)
  • Hydromorphone (13)
  • Cocaine (8)
  • Benzodiazepines (7)
  • Heroin (7)
  • Morphine (6)
  • Marijuana (Cannabis) (4)
  • Amphetamines (3)
  • Methadone (3)
  • Steroids (3)
  • Ketamine (1)
  • Marijuana Concentrates (1)
  • Xylazine (1)

Field Division

  • Washington, DC (41)
  • Houston (40)
  • New England (35)
  • New York (29)
  • Seattle (28)
  • Omaha (23)
  • Atlanta (19)
  • Chicago (19)
  • New Jersey (17)
  • Rocky Mountain (17)
  • Sede (16)
  • Miami (15)
  • Louisville (14)
  • New Orleans (14)
  • St. Louis (14)
  • Los Angeles (13)
  • El Paso (10)
  • Phoenix (8)
  • San Francisco (8)
  • Dallas (5)
  • San Diego (4)
  • Detroit (1)
Clear All Results
PRESS RELEASE

DEA’s Third Annual National Family Summit on Fentanyl Highlights Progress in Fight to Save Lives

Noviembre 15, 2024
WASHINGTON – The U.S. Drug Enforcement Administration hosted the third annual National Family Summit on Fentanyl on November 14 and 15. For the past three years, DEA has invited families who have lost a loved one to a fentanyl drug poisoning or overdose to gather in the nation’s capital and...
Noviembre 15, 2024
PRESS RELEASE

Nearly 630,000 Pounds of Unneeded Medications Collected on DEA’s National Prescription Drug Take Back Day

Noviembre 15, 2024
MIAMI — Drug Enforcement Administration (DEA) and more than 4,400 law enforcement partners recently collected nearly 630,000 pounds of unused medications at 4,600 locations nationwide. This effort to empty medicine cabinets helps prevent drug misuse before it starts. Since its inception, DEA’s National Prescription Drug Take Back Day has removed...
Noviembre 15, 2024
PRESS RELEASE

Beaumont Man Sentenced to Federal Prison for Trafficking Fentanyl

Noviembre 14, 2024
BEAUMONT, Texas – A Beaumont man has been sentenced to federal prison for possessing fentanyl for distribution in the Eastern District of Texas, announced Drug Enforcement Administration (DEA) Special Agent in Charge Daniel C. Comeaux of the Houston Division and U.S. Attorney Damien M. Diggs. Harry Francis Lowenthal, 66, pleaded...
Noviembre 14, 2024
PRESS RELEASE

DEA Billboard in Omaha Looks to Re-Energize Conversations on Fentanyl Dangers

Noviembre 12, 2024
The Drug Enforcement Administration (DEA) Omaha Division is taking the One Pill Can Kill message to new heights with a billboard placed along Interstate 80 in Omaha, emphasizing the deadly consequences of fake pills laced with fentanyl. Vehicles traveling east on Interstate 80 will see the 14x48 foot billboard along...
Noviembre 12, 2024
PRESS RELEASE

China-Based Chemical Company, Its Director and Senior Employees Indicted for Alleged Fentanyl Manufacturing and Distribution

Noviembre 08, 2024
LOS ANGELES – A chemical company, its director and three senior employees have been charged in a 13-count federal grand jury indictment alleging they sold deadly fentanyl precursor chemicals and xylazine – known as “tranq” – globally, fueling the fentanyl crisis in the United States, the Justice Department announced today...
Noviembre 08, 2024
PRESS RELEASE

Covetrus Agrees To Pay $1,125,000 for Failing to Adequately Address Suspicious Opioid Orders and for Inadequate Recordkeeping Practices

Octubre 30, 2024
BOSTON – The U.S. Attorney’s Office has reached a $1,125,000 settlement with Covetrus North America, LLC (Covetrus NA) to resolve allegations that it violated the Controlled Substances Act and related regulations. Covetrus NA, headquartered in Portland, Maine, is a company that distributes veterinary medicine to customers worldwide. Under the settlement...
Octubre 30, 2024
PRESS RELEASE

U.S. Attorney’s Office and DEA Announce Fatal Fentanyl Overdose Task Force

Octubre 28, 2024
Baltimore, Maryland – Erek L. Barron, U.S. Attorney for the District of Maryland and Jarod Forget, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) Washington Division, announced that their agencies have formed the Maryland Fatal Fentanyl Overdose Task Force (“MFFOTF”). The alarming rate of overdoses in Maryland has...
Octubre 28, 2024
PRESS RELEASE

Humble Resident Arrested in Connection to Fatal Fentanyl Overdose

Octubre 24, 2024
HOUSTON – A 22-year-old man has been taken into custody in connection to the fentanyl overdose death of a Houston resident, announced U.S. Attorney Alamdar S. Hamdani. Law enforcement arrested Cole Martin Millsap Oct. 23. He is set to make his initial appearance before U.S. Magistrate Judge Dena Hanovice Palermo...
Octubre 24, 2024
PRESS RELEASE

Physician, Physician Assistant, and Practice Pay $300K to Resolve Controlled Substances Act Allegations

Octubre 23, 2024
BERLIN, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, and Stephen P. Belleau, Acting Special Agent in Charge of the Drug Enforcement Administration for New England, today announced that Dr. STEVEN SHIFREEN, Physician Assistant CHRISTOPHER NORVAL, and MULTICARE MUSCULOSKETETAL MEDICINE AND PAIN MANAGEMENT ASSOCIATES, P.C...
Octubre 23, 2024
PRESS RELEASE

Former Nurse Pleads Guilty in Connection with Diverting Fentanyl from ICU Patient

Octubre 08, 2024
CONCORD, N.H. – A Northfield woman has pleaded guilty in federal court for diverting fentanyl from an ICU patient at Concord Hospital, U.S. Attorney Jane E. Young announces. Lisa Richardson, 48, pleaded guilty to one count of Tampering with Consumer Products. U.S. District Court Judge Landya McCafferty scheduled sentencing for...
Octubre 08, 2024
Showing 91 - 100 of 391 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 6
  • Página 7
  • Página 8
  • Página 9
  • Current page 10
  • Página 11
  • Página 12
  • Página 13
  • Página 14
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster